These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2327767)
1. Influence of clavulanic acid on the activity of amoxicillin against an experimental Streptococcus pneumoniae-Staphylococcus aureus mixed respiratory infection. Smith GM; Boon RJ; Beale AS Antimicrob Agents Chemother; 1990 Feb; 34(2):210-4. PubMed ID: 2327767 [TBL] [Abstract][Full Text] [Related]
2. Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice. Gisby J; Wightman BJ; Beale AS Antimicrob Agents Chemother; 1991 May; 35(5):831-6. PubMed ID: 1854164 [TBL] [Abstract][Full Text] [Related]
3. Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes. Boon RJ; Beale AS Antimicrob Agents Chemother; 1987 Aug; 31(8):1204-9. PubMed ID: 3307617 [TBL] [Abstract][Full Text] [Related]
4. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or beta-lactamase-producing Haemophilus influenzae. Smith GM; Abbott KH Antimicrob Agents Chemother; 1994 Mar; 38(3):608-10. PubMed ID: 8203862 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat. Catherall EJ; Irwin R; Mizen LW J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588 [TBL] [Abstract][Full Text] [Related]
6. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors. White A; Cooper C; Stokes D Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934 [No Abstract] [Full Text] [Related]
7. Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid. Fiocchi A; Zuccotti G; Bellù R; Marangione P; Riva E; Giovannini M J Int Med Res; 1990; 18(4):326-33. PubMed ID: 2227080 [TBL] [Abstract][Full Text] [Related]
8. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Woodnutt G; Berry V Antimicrob Agents Chemother; 1999 Jan; 43(1):29-34. PubMed ID: 9869561 [TBL] [Abstract][Full Text] [Related]
9. Activity of amoxicillin-clavulanate against penicillin-resistant Streptococcus pneumoniae in an experimental respiratory infection model in rats. Smith GM; Slocombe B; Abbott KH; Mizen LW Antimicrob Agents Chemother; 1998 Apr; 42(4):813-7. PubMed ID: 9559788 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Woodnutt G; Berry V Antimicrob Agents Chemother; 1999 Jan; 43(1):35-40. PubMed ID: 9869562 [TBL] [Abstract][Full Text] [Related]
11. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid. Brook I; Foote PA; Hausfeld JN Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017 [TBL] [Abstract][Full Text] [Related]
12. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Todd PA; Benfield P Drugs; 1990 Feb; 39(2):264-307. PubMed ID: 2184003 [TBL] [Abstract][Full Text] [Related]